• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Oxford Nanopore Technologies PLC (ONT)

ORD GBP0.0001
Sell: 174.30p|Buy: 175.00p|Change: 3.60 (2.11%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Company profile

Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy touse, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.

Address

Edmund Halley Road
Gosling Building, Oxford Science Park
Oxford
Oxfordshire
GBR
OX44DQ

Telephone

+44 8450347900

Website

https://www.nanoporetech.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Oxford Nanopore Technologies PLC Second Quarter Earnings Conference Call for 20272027-08-19T04:30:00
Oxford Nanopore Technologies PLC Second Quarter Earnings Results for 20272027-08-19T00:00:00
Oxford Nanopore Technologies PLC Annual General Meeting for 20272027-06-04T10:30:00
Oxford Nanopore Technologies PLC Annual Report for 20262027-04-30T00:00:00
Oxford Nanopore Technologies PLC Fourth Quarter Earnings Conference Call for 20262027-03-02T16:30:00
Oxford Nanopore Technologies PLC Fourth Quarter Earnings Results for 20262027-03-02T00:00:00
RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference2026-09-22T10:15:00
Morgan Stanley Global Healthcare Conference2026-09-15T10:45:00

Previous key dates

NameKey Date
RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference2026-09-22T10:15:00
Morgan Stanley Global Healthcare Conference2026-09-15T10:45:00
Oxford Nanopore Technologies PLC Second Quarter Earnings Conference Call for 20262026-08-19T04:30:00
Oxford Nanopore Technologies PLC Second Quarter Earnings Result for 20262026-08-19T00:00:00
Oxford Nanopore Technologies PLC Annual General Meeting for 20262026-06-04T10:30:00
Oxford Nanopore Technologies PLC Annual Report for 20252026-05-01T00:00:00
Oxford Nanopore Technologies PLC Fourth Quarter Earnings Conference Call for 20252026-03-02T16:30:00
Oxford Nanopore Technologies PLC Fourth Quarter Earnings Result for 20252026-03-02T00:00:00
Oxford Nanopore Technologies PLC Second Quarter Earnings Conference Call for 20252025-09-02T04:00:00
Oxford Nanopore Technologies PLC Second Quarter Earnings Result for 20252025-09-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.